Divis Labs (Bullish stance)
Divis Labs:
Sector: Pharma and Biotechnology
Industry: Pharma
Divis Laboratories (Weekly):
1. Double Bottom
2. Breakout of Double Bottom
3. Positive Crossover of 5,13 Weeks Exponential Moving Average
Daily:
1. RSI Bullish Divergence and Double Bottom Breakout
2. Trendline Breakout
3. Good to buy above consolidation breakout (closing above 4590)
4. Positive crossover of 5,13 Days Exponential Moving Average
5. Trading above 200 Days Exponential Moving Average
Addl Points:
1. FII/FPI have decreased holdings from 19.30% to 18.45% in Mar 2022 qtr
2. Mutual Funds have increased holdings from 13.35% to 13.68% in Mar 2022 qtr.
Note:
1. The above analysis is just for educational purpose.
Sector: Pharma and Biotechnology
Industry: Pharma
Divis Laboratories (Weekly):
1. Double Bottom
2. Breakout of Double Bottom
3. Positive Crossover of 5,13 Weeks Exponential Moving Average
Daily:
1. RSI Bullish Divergence and Double Bottom Breakout
2. Trendline Breakout
3. Good to buy above consolidation breakout (closing above 4590)
4. Positive crossover of 5,13 Days Exponential Moving Average
5. Trading above 200 Days Exponential Moving Average
Addl Points:
1. FII/FPI have decreased holdings from 19.30% to 18.45% in Mar 2022 qtr
2. Mutual Funds have increased holdings from 13.35% to 13.68% in Mar 2022 qtr.
Note:
1. The above analysis is just for educational purpose.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.